FTO and metabolic dysfunction-associated steatohepatitis: FTO was distributed in all cell populations and was highly expressed in NAFLD tissues at different pathological stages, especially in NASH with cirrhosis and in the end‐stage state (Figure 7B,C), which again demonstrated that the FTO gene plays an important role in the pathogenesis of NAFLD.